ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1096

Is Vitamin D Deficiency a Risk Factor For The Development Of Statin Induced Myalgia, In Patients Treated With Statin?

Ozlem Tasoglu1, Yesim Kutsal1, Irfan Tasoglu2, Oya Ozdemir3 and Yildiz Erdoganoglu4, 1Physical Medicine and Rehabilitation, Hacettepe University Faculty of Medicine, Ankara, Turkey, 2Cardiovascular Surgery, Türkiye Yuksek Ihtisas Training and Research Hospital, Ankara, Turkey, 3Department of Physical Medicine and Rehabilitation, Hacettepe University Faculty of Medicine, Ankara, Turkey, 4Physiotherapy, Hacettepe University, Ankara, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Musculoskeletal, pain and statins, Vitamin D

  • Tweet
  • Email
  • Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders and Pain II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Vitamin D deficiency has become pandemic in the industrializing societies. Recently, the role of vitamin D deficiency in the development of statin myopathy has started to be discussed. The purpose of this study is to compare the serum vitamin D levels and objective muscle strength measures in males with or without myalgia who were under statin treatment.

Methods : Seventeen patients (mean age: 49,1± 7,9) with a diagnosis of statin induced myalgia and 23 patients  (mean age: 50,6± 9,0) without myalgia were included in this study. The patients in the two groups  were matched according to age, level of physical activity and sunlight exposure. After a detailed physical examination, serum 25-OH vitamin D levels were measured. The patients with myalgia were asked to complete a 10 cm Visual Analog Scale (VAS) and McGill–Melzack Pain Questionnaire. The measurement of grip strength were performed using Jamar type hydraulic hand dynamometer, and isometric/isokinetic measurements of the biceps and quadriceps muscles were performed using Biodex System 3 device.

Results :  Statin dosages (mg) were: 19,1±16,7 (myalgia) and 17,0±7,7(without myalgia) (p value: 0,639) and durations (month) were: 32,9±28,4 (myalgia) and 40,4±39,4 (without myalgia (p value: 0,606).There was no significant difference in the mean values of vitamin D levels in both groups (myalgia: 34,8 ng/mL,  without myalgia:31,9 ng/mL). In general, the patients with statin induced myalgia had an intermittant pain in the proximal parts of their extremities. They declared that the pain was induced by activity or exercise and reduced with rest. The mean VAS score was determined as 4.0 cm (min:1.3, max:8.4). No statistically significant correlations were found between the vitamin D levels and any of the pain parameters in the myalgia group (p>0,05).  Furthermore, the measurement with the hand dynamometer and the isometric and isokinetic muscular strength analyses for both groups were found to be similar except for the biceps isokinetic 120º TT/VA.

Conclusion : The male patients with or without statin induced myalgia have similar serum vitamin D levels and muscle strength. Thus, it seems like vitamin D deficiency might not be a risk factor for the development of statin induced myalgia.


Disclosure:

O. Tasoglu,
None;

Y. Kutsal,
None;

I. Tasoglu,
None;

O. Ozdemir,
None;

Y. Erdoganoglu,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-vitamin-d-deficiency-a-risk-factor-for-the-development-of-statin-induced-myalgia-in-patients-treated-with-statin/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology